Titre:
  • Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes.
Auteur:Vermeire, Séverine; Hanzel, Jurij; Löwenberg, Mark; Ferrante, Marc; Bossuyt, Peter; Hoentjen, Frank; Franchimont, Denis; Palatka, Károly; Peeters, Harald; Mookhoek, Aart; De Hertogh, Gert; Molnár, Tamás T.F.; Van Moerkercke, W.; Lobatòn, Triana; Clasquin, Esme; Hulshoff, Melanie M.S.; Baert, Filip; D'Haens, Geert; LOVE-UC study group,
Informations sur la publication:Journal of Crohn's and Colitis, 18, 4, page (540-547)
Statut de publication:Publié, 2024-04-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:LOVE-UC Trial
anti-integrin
biologic
inflammatory bowel disease
MeSH keywords:Humans
Colitis, Ulcerative -- drug therapy -- pathology
Antibodies, Monoclonal, Humanized -- administration & dosage -- therapeutic use
Female
Male
Adult
Gastrointestinal Agents -- administration & dosage -- therapeutic use
Middle Aged
Remission Induction -- methods
Treatment Outcome
Colonoscopy
Severity of Illness Index
Langue:Anglais
Identificateurs:urn:issn:1873-9946
info:doi/10.1093/ecco-jcc/jjad179
info:pii/7338812
info:pmid/37934813